Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study.

Autor: Samaras P; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: panagiotis.samaras@uzh.ch., Rütti MF; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Seifert B; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland., Bachmann H; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Schanz U; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Eisenring M; Department of Immunology, University Hospital Zurich, Zurich, Switzerland., Renner C; Oncology Center, Hirslanden Clinic Zurich, Zurich, Switzerland., Susanne Müller AM; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Schmidt A; Medical Oncology and Hematology, Triemli City Hospital Zurich, Zurich, Switzerland., Mischo A; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Fuchs I; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Bargetzi M; Center of Oncology, Hematology and Transfusion Medicine, Cantonal Hospital Aarau, Aargau, Switzerland., Manz MG; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Stupp R; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Petrausch U; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland., Stenner-Liewen F; Center for Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 Apr; Vol. 24 (4), pp. 694-699. Date of Electronic Publication: 2017 Dec 12.

Deoxysphingoid bases as plasma markers in diabetes mellitus.

Autor: Bertea M; Institute for Clinical Chemistry, University Hospital Zurich and Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland., Rütti MF, Othman A, Marti-Jaun J, Hersberger M, von Eckardstein A, Hornemann T

Publikováno v: Lipids in health and disease [Lipids Health Dis] 2010 Aug 16; Vol. 9, pp. 84. Date of Electronic Publication: 2010 Aug 16.

An improved method to determine serine palmitoyltransferase activity.

Autor: Rütti MF; Institute for Clinical Chemistry, University Hospital Zurich, CH-8091 Zurich, Switzerland., Richard S, Penno A, von Eckardstein A, Hornemann T

Publikováno v: Journal of lipid research [J Lipid Res] 2009 Jun; Vol. 50 (6), pp. 1237-44. Date of Electronic Publication: 2009 Jan 29.

Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase.

Autor: Hornemann T; Institute for Clinical Chemistry, University Hospital Zürich, Rämistrasse 100, CH-8091 Zürich, Switzerland. thorsten.hornemann@usz.ch, Richard S, Rütti MF, Wei Y, von Eckardstein A

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2006 Dec 08; Vol. 281 (49), pp. 37275-81. Date of Electronic Publication: 2006 Oct 04.

The atypical sphingosine 1‐phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma.

Autor: Glueck, Melanie¹ (AUTHOR) m.glueck@blutspende.de, Koch, Alexander¹ (AUTHOR), Brunkhorst, Robert² (AUTHOR), Ferreiros Bouzas, Nerea³ (AUTHOR), Trautmann, Sandra³ (AUTHOR), Schaefer, Liliana¹ (AUTHOR), Pfeilschifter, Waltraud^1,4 (AUTHOR), Pfeilschifter, Josef¹ (AUTHOR), Vutukuri, Rajkumar¹ (AUTHOR) vutukuri@med.uni-frankfurt.de

Publikováno v: FEBS Journal. Sep2022, Vol. 289 Issue 18, p5670-5681. 12p.